Clinical Trials in North Carolina

Showing 1221-1240 of 17,526 trials

Pulse Oximetry Performance Comparison in Newborns

NCT06637917

The overall purpose is to directly compare pulse rate (PR) acquisition and oxygen saturation performance between two pulse oximeters (PO) in newborns.

NewbornBirth, Preterm

Medtronic - MITG120 participantsStarted Sep 2024

Los Angeles, California, United States • St Louis, Missouri, United States • Winston-Salem, North Carolina, United States

RECRUITINGPhase 341 miles

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

NCT06813911

The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp(a)), and who are on background inclisiran treatment for elevated low-density lipoprotein cholesterol (LDL-C).

Atherosclerotic Cardiovascular Disease (ASCVD)

Novartis Pharmaceuticals340 participantsStarted Apr 2025

Birmingham, Alabama, United States • Sun City West, Arizona, United States • Beverly Hills, California, United States +77 more locations

Pulse Oximetry Performance Comparison in Newborns

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Find Trials by Condition in North Carolina

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A Study of miRNA 371 in Patients With Germ Cell Tumors

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

F15 Recharge Free Axonics SNM System Clinical Study

The Fourth Left Atrial Appendage Occlusion Study

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma